VVX insiders have traded $VVX stock on the open market 14 times in the past 6 months. Of those trades, 7 have been purchases and 7 have been sales. Here’s a ...

Vertex AI and high performance computing make it faster and easier to detect space storms SUNNYVALE, Calif., Jan. 28, 2025 /PRNewswire/ -- The Aerospace Corporation (Aerospace), a national ...

CPI Readings Due in U.S. Next Week Monday U.S. Featured Earnings McDonalds (NYSE:MCD) (Q4) EPS of $2.82 compared to $2.95 in ...

Qatar’s VC (venture capital) funding reported a remarkable 135% year-on-year rise to an all-time high of QR115mn in 2024, ...

Today's Research Daily features a real-time update on the Q4 earnings season, in addition to new research reports on Alphabet, (GOOGL), Blackstone (BX), KLA Corporation (KLAC) and other companies as ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), UnitedHealth ...

Factory automation Sensor market Size & Growth Report Driven by industry 4.0, IoT integration, and the demand for smarter manufacturing, efficiency and automation are enhanced across various ...

After hours: January 29, 7:58:05 p.m. EST Vertex Baseline Delta ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.